Product Information
ZIOPTAN 0.0015% EYE DROP is a brand product labeled by Thea Pharma Inc., priced at $8.4944 per EA under NDC 82584060930. Its NADAC has been published 167 times since Apr 19, 2023.
The High Outlier badge above means this manufacturer's average price in the Tafluprost market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.015 mg/mL
Manufacturer
Thea Pharma Inc.NDC
82584060930
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
TAFLUPROSTApproval Type
New Drug (NDA)
FDA Application
NDA202514On Market Since
10/28/2022
Pharmacological Classes
Price Statistics
The NADAC for ZIOPTAN 0.0015% EYE DROP has been published 167 times since Apr 19, 2023, and over the history we have for it it has risen 15.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.4944 per EA |
|---|---|
| All-time high | $8.5184 (Dec 11, 2024) |
| All-time low | $7.3424 (Apr 19, 2023) |
| 52-week high | $8.5004 |
| 52-week low | $8.4857 |
| Median price | $8.4932 |
| Average price | $8.2867 |
| Largest weekly change | +8.0% (May 8, 2024) |
| Weeks tracked | 167 |
| Tracking since | Apr 19, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ZIOPTAN 0.0015% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for ZIOPTAN 0.0015% EYE DROP, manufactured by Thea Pharma Inc., is $8.4944 per EA (NDC 82584060930), effective Jun 24, 2026.
How has the price of ZIOPTAN 0.0015% EYE DROP changed over time?
Over the history we have for it, the NADAC for ZIOPTAN 0.0015% EYE DROP has risen 15.7%. It has been tracked across 167 weekly CMS publications since Apr 19, 2023.
What are the highest and lowest recorded NADAC prices for ZIOPTAN 0.0015% EYE DROP?
Since Apr 19, 2023, the NADAC for ZIOPTAN 0.0015% EYE DROP has ranged from a low of $7.3424 (Apr 19, 2023) to a high of $8.5184 (Dec 11, 2024), with a median of $8.4932 per EA.
Are there cheaper alternatives to ZIOPTAN 0.0015% EYE DROP?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, TAFLUPROST 0.0015% EYE DROP, is $2.5020 per EA — about 71% below ZIOPTAN 0.0015% EYE DROP.
Who manufactures ZIOPTAN 0.0015% EYE DROP?
ZIOPTAN 0.0015% EYE DROP (NDC 82584060930) is labeled by Thea Pharma Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification